CD34 and neoplasm: By applying CD34+ humanized NCG mice model and PCCA cell model analysis, we further found that Siah2 enhanced in vivo antitumor T-cell immunity in a PD-L1–dependent manner, unveiling a complex role of Siah2 in the tumor-immune microenvironment.